Hypercalcemia associated with hematologic malignancies.

[1]  K. Norrby,et al.  Hypercalcaemia in chronic lymphatic leukaemia. , 2009, Scandinavian journal of haematology.

[2]  R. Vassilopoulou-sellin,et al.  Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center , 1993, Cancer.

[3]  T. Yoneda,et al.  Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. , 1993, Cancer research.

[4]  E. Ogata,et al.  Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells. , 1993, The Journal of biological chemistry.

[5]  Y. Nakamura,et al.  Serum parathyroid hormone-related protein concentrations in patients with hematologic malignancies or solid tumors. , 1992, Acta endocrinologica.

[6]  T. Martin,et al.  Hypercalcemia in cancer , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  S. Johnston,et al.  Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia-lymphoma. , 1992, Postgraduate medical journal.

[8]  S. Hanada,et al.  Tumor Necrosis Factor- and Hypercalcemia , 1992 .

[9]  R. Yamashita,et al.  [Acute lymphocytic leukemia (L1) preceded by hypercalcemia]. , 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[10]  T. Lister,et al.  Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcaemia. , 1991, British Journal of Cancer.

[11]  Y. Hara,et al.  Two cases of adult T-cell leukemia associated with acute pancreatitis due to hypercalcemia. , 1991, The American journal of medicine.

[12]  K. Yamaguchi,et al.  Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene , 1990, The Journal of experimental medicine.

[13]  Syuji Hashimoto,et al.  Hypercalcaemia and serum TNF-α in T-cell leukaemia , 1990, The Lancet.

[14]  E. Ogata,et al.  Parathyroid hormone-related protein in adult T-cell leukemia-lymphoma. , 1989, Annals of internal medicine.

[15]  K. Kasono,et al.  Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. , 1989, Endocrinology.

[16]  G. Mundy.  Hypercalcemia of malignancy revisited. , 1988, The Journal of clinical investigation.

[17]  N. Esumi,et al.  Hypercalcemia in a case of childhood acute lymphoblastic leukemia. , 1987, Japanese journal of clinical oncology.

[18]  T. Bringman,et al.  Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. , 1987, The New England journal of medicine.

[19]  F. Breedveld,et al.  Ectopic production of 1,25‐dihydroxyvitamin D by B‐cell lymphoma as a cause of hypercalcemia , 1987, Cancer.

[20]  S. Cohn,et al.  The spectrum of metabolic bone disease in lymphoblastic leukemia , 1987, Cancer.

[21]  E. Mawer,et al.  ABNORMAL VITAMIN D METABOLISM IN HODGKIN'S LYMPHOMA , 1985, The Lancet.

[22]  W. Blattner,et al.  Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. , 1983, The New England journal of medicine.

[23]  E. Jaffe,et al.  The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. , 1983, Blood.

[24]  T. Martin,et al.  The hypercalcemia of malignancy: pathogenesis and management. , 1982, Metabolism: clinical and experimental.

[25]  M. Greaves,et al.  ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES , 1982, The Lancet.

[26]  G. Mundy,et al.  Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma , 1981, British journal of haematology.

[27]  G. Mundy,et al.  PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATION , 1980, The Lancet.

[28]  M. Greene,et al.  Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma. , 1978, The American journal of medicine.

[29]  G. Mundy,et al.  Evidence for the secretion of an osteoclast stimulating factor in myeloma. , 1974, The New England journal of medicine.

[30]  G. Canellos.  HYPERCALCEMIA IN MALIGNANT LYMPHOMA AND LEUKEMIA , 1974, Annals of the New York Academy of Sciences.

[31]  D. Watkin,et al.  POSTOPERATIVE WOUND INFECTION. , 1965, Lancet.

[32]  F. King,et al.  Hypercalcemia in Hodgkin's disease. , 1957, The New England journal of medicine.

[33]  M. Senba,et al.  Metastatic calcification due to hypercalcemia in adult T-cell leukemia-lymphoma (ATLL). , 1991, Zentralblatt fur Pathologie.

[34]  R. Kyle.  Monoclonal gammopathies and the kidney. , 1989, Annual review of medicine.

[35]  J. Adams,et al.  Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. , 1989, Blood.

[36]  A. F. Stewart,et al.  Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. , 1985, The Journal of clinical endocrinology and metabolism.

[37]  G. Zaloga,et al.  Humoral hypercalcemia in Hodgkin's disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption. , 1985, Archives of internal medicine.

[38]  E. Frenkel,et al.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. , 1984, Annals of internal medicine.